Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib in Metastatic Thyroid Cancer
NCT00654238Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Feb 2006
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in thyroid cancer, sponsored by University of Pennsylvania. Started Feb 2006; status: completed.
02
Drugs
sorafenib
03
Conditions
thyroid cancer
Beyond the preview
Go deeper on NCT00654238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00654238.